Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.

MLA

Salerno, Loredana, et al. “Evaluation of Novel Aryloxyalkyl Derivatives of Imidazole and 1,2,4-Triazole as Heme Oxygenase-1 (HO-1) Inhibitors and Their Antitumor Properties.” Bioorganic & Medicinal Chemistry, vol. 21, no. 17, Sept. 2013, pp. 5145–53. EBSCOhost, https://doi.org/10.1016/j.bmc.2013.06.040.

APA

Salerno, L., Pittalà, V., Romeo, G., Modica, M. N., Siracusa, M. A., Di Giacomo, C., Acquaviva, R., Barbagallo, I., Tibullo, D., & Sorrenti, V. (2013). Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties. Bioorganic & Medicinal Chemistry, 21(17), 5145–5153. https://doi.org/10.1016/j.bmc.2013.06.040

Chicago

Salerno, Loredana, Valeria Pittalà, Giuseppe Romeo, Maria N. Modica, Maria A. Siracusa, Claudia Di Giacomo, Rosaria Acquaviva, Ignazio Barbagallo, Daniele Tibullo, and Valeria Sorrenti. 2013. “Evaluation of Novel Aryloxyalkyl Derivatives of Imidazole and 1,2,4-Triazole as Heme Oxygenase-1 (HO-1) Inhibitors and Their Antitumor Properties.” Bioorganic & Medicinal Chemistry 21 (17): 5145–53. doi:10.1016/j.bmc.2013.06.040.